Completed Infection & Immunity

Characterisation, determinants, mechanisms and consequences of the long-term effects of COVID-19: providing the evidence base for health care services

In plain English

AI plain-English summary

Around 200 people who had COVID-19 will wear heart-rate and respiration monitors, complete online mental-health questionnaires, and attend clinics for organ scans, as part of a study to define and diagnose the different forms of long COVID. Most COVID-19 infections do not lead to hospitalisation, so population studies are the best way to understand long COVID’s individual and societal toll. This project links national primary care registries—which capture everyone who visits their GP—with population cohorts that include people who never sought care. That combination allows researchers to separate the effects of infection from the progression of pre-existing conditions. If successful, the work will produce clearer diagnostic criteria for long COVID’s sub-phenotypes, identify which patients are most likely to develop them, and reveal the biological mechanisms driving each subtype. The researchers will also measure how well GPs follow NICE guidelines for diagnosis and management, and pilot a pop-up tool in medical records to improve adherence. The ultimate goal is to give the NHS evidence-based pathways for bespoke treatment and long-term health-service planning—turning a poorly understood syndrome into something clinicians can reliably diagnose and manage.

View original technical description
Long-term health consequences of C-19 (long-COVID) occur frequently. Most infections are not hospitalised; population studies are the place to understand individual and societal challenges of long-COVID. We will address the following questions: How do we define and diagnose the sub-phenotypes of long-COVID? What are the predictors of long-COVID, and what are the mechanisms of the sub-phenotypes? What are the long-term health (physical and mental), and socioeconomic consequences? What factors enhance recovery? What is the level of GP adherence to NICE diagnosis and management guidelines? Can a pop-up tool in medical records enhance adherence? We have an established consortium of experts and platforms uniting linked national primary care registries and population cohorts. The national coverage of primary care registries captures all individuals presenting to their GP, with linked prescribing, consulting, referral and outcome data. Many with long-COVID do not seek care. Population cohorts, with repeat C-19 related questionnaires, overcome this limitation. Further, the standardised pre-pandemic health data enables dissection of the effects of infection versus progression of co-morbidity. Questionnaires will identify long-COVID cases across cohorts. A subgroup of 200 cases will be matched to three sets of controls (C-19 +, long-COVID-), (C-19-, long-COVID+), and (C-19-, long-COVID-). They will wear a device capturing exercise capacity, heart rate and respiration, and complete regular online questionnaires on mental health and cognition. They will attend clinic for imaging to assess target organ damage. Qualitative work with people with long-COVID will inform diagnostic criteria and understanding of the lived experience. Parallel analysis of cohorts and registries will address each question. With NICE, we will quantify adherence to diagnostic and management guidelines in GP records, and pilot a pop-up intervention to enhance adherence. Our findings will enhance diagnostic criteria, identify pathways for bespoke sub-phenotype intervention, and inform plans for health service delivery.

View the original record at the funder ↗

Related Research

Grants with similar aims, by meaning.

Characterisation, determinants, mechanisms and consequences of the long-term effects of COVID-19: providing the evidence base for health care
STIMULATE-ICP (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways)
Therapies for Long COVID in non-hospitalised individuals: From symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study)
STIMULATE ICP - A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with Long COVID
Impact of social, economic, and demographic factors in disparity in clinical coding of long COVID in national electronic health records

Original classification

Research

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.